Vistin Pharma ASA (VISTNo)
CBOE 
Summary
Vistin Pharma ASA (VISTNo) FAQ
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Vistin Pharma ASA ever had a stock split?
Vistin Pharma ASA Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Magnus Tolleshaug CEO | CBOE Exchange | - ISIN |
| Norway Country | 73 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Vistin Pharma ASA, with its subsidiary Vistin Pharma AS, stands as a prominent producer and marketer of active pharmaceutical ingredients (APIs) on a global scale. The company has been established since 1969, affirming its long-standing presence and expertise within the pharmaceutical industry. Rooted in Oslo, Norway, Vistin Pharma ASA has grown significantly over the years to serve a wide range of customers across various geographies, showcasing its international footprint and dedication to providing high-quality pharmaceutical products.
Products and Services
- Metformin HCl APIs
- Direct Compressive Granulates
This product line features high-quality Active Pharmaceutical Ingredients (APIs) of Metformin Hydrochloride (HCl), a widely used medication for treating type 2 diabetes. Vistin Pharma’s Metformin HCl APIs are developed using state-of-the-art technology to ensure purity, efficacy, and safety, meeting the critical needs of pharmaceutical manufacturers around the world.
Vistin Pharma also specializes in the production of direct compressive granulates. This offering simplifies the tablet manufacturing process for the pharmaceutical industry by providing ready-to-use granulated forms of APIs that facilitate easier handling and processing. These granulates are designed to ensure uniformity and consistency in the production of pharmaceutical tablets, enhancing efficiency and product quality.
